Faculty profile

Raphael Schneider

Back to faculty

Assistant ProfessorDepartment of MedicineUniversity of Toronto

Raphael Schneider

Assistant Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
25 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.
Supervised 1 trainee who won CIHR awards, most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Education

Profiles and links

University Profile Search on Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Blood Biomarkers Imaging Biomarkers

Latest papers

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial.
Journal of Alzheimer's disease : JAD · 2026
When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?
Current neurology and neuroscience reports · 2026 · senior author
Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis.
Brain : a journal of neurology · 2026

All 46 publications

Latest funding

NfL, GFAP, CHI3L1 and advanced imaging measures as biomarkers of disease progression in the Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis (CanProCo)
CIHR · 2025 · Nominated PI
$684,675
Investigating the CXCR4/CXCL12 axis to predict multiple sclerosis disease onset
CIHR · 2024 · Supervisor
$120,000

All 2 grants and awards

46 publications.

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial.

Rashidi-Ranjbar N, Churchill NW, Jerkic M, Zomorrodi R, Rotstein O, Schneider R, Andreazza AC, Rajji TK, Graham SJ, Munoz DG, Fornazzari L, Lim L, Norris M, Schweizer TA, Fischer CE

Journal of Alzheimer's disease : JAD2026

DOI: 10.1177/13872877261453911 PMID: 42231857

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Van Horebeek L, Das A, Neufeld J, Schneider R

Current neurology and neuroscience reports2026Senior author

DOI: 10.1007/s11910-026-01495-1 PMID: 42029833

Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis.

Bigotte M, Groh AMR, Afanasiev E, Wong V, Lancon K, Yaqubi M, Creeggan F, Sinott A, Pei J, Moore CS, Harroud A, Schneider R, Séguéla P, Charabati M, Tea F, Fournier AP, Wang YC, Ragoussis J, Prat A, Thebault S, Zandee S, Stratton JA

Brain : a journal of neurology2026

DOI: 10.1093/brain/awaf440 PMID: 41277219

Plasma CHI3L1 as a marker of cognitive and structural brain changes in radiologically isolated syndrome.

Schneider R, Brand-Arzamendi K, Lim TR, Lee LE, Guenette M, Hu Z, Colak E, Suthiphosuwan S, Bharatha A, Feinstein A, Oh J

BMJ neurology open2026First author

DOI: 10.1136/bmjno-2025-001301 PMID: 41953284

Eye tracking as a digital biomarker in neurodegenerative diseases.

Giacomini PS, Voss P, Devonshire V, Schneider R, Macaron G, Hussein S, Blanchette F, de Villers-Sidani É

Journal of neurology2026

DOI: 10.1007/s00415-026-13666-8 PMID: 41665706

Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal banding and associated tests for multiple sclerosis (MS): a consensus report from the harmonized CSF analysis for MS investigation (hCAMI) subcommittee of the Canadian society of clinical chemists (CSCC)

Higgins V, Parker ML, Ahmed B, Bhayana V, Booth RA, Chen Y, Collier C, Freedman MS, Gagné M, Ismail OZ

Clinical Biochemistry20261 citations

DOI: 10.1016/j.clinbiochem.2026.111098

Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis.

Itorralba J, Brand-Arzamendi K, Saab G, Muccilli A, Schneider R

BMC neurology2025Senior author

DOI: 10.1186/s12883-025-04145-0 PMID: 40175894

Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay.

Booth RA, Beriault D, Schneider R, Benkert P, Willemse EAJ, Maceski AM, Leppert D, Freedman MS, Kuhle J

Clinica chimica acta; international journal of clinical chemistry2025

DOI: 10.1016/j.cca.2025.120447 PMID: 40562335

Pro-Inflammatory Molecules Implicated in Multiple Sclerosis Divert the Development of Human Oligodendrocyte Lineage Cells.

Blaszczyk GJ, Mohammadnia A, Piscopo VEC, Sirois J, Cui QL, Yaqubi M, Durcan TM, Schneider R, Antel JP

Neurology(R) neuroimmunology & neuroinflammation2025

DOI: 10.1212/nxi.0000000000200407 PMID: 40393021

Monocyte-secreted Wnt reduces the efficiency of central nervous system remyelination.

Hill BM, Holloway RK, Forbes LH, Davies CL, Monteiro JK, Brown CM, Rose J, Fudge N, Plant PJ, Mahmood A, Brand-Arzamendi K, Kent SA, Molina-Gonzalez I, Gyoneva S, Ransohoff RM, Wipke B, Priller J, Schneider R, Moore CS, Miron VE

PLoS biology2025

DOI: 10.1371/journal.pbio.3003073 PMID: 40233100

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Blood Biomarkers Dear Professor Schneider, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "NfL, GFAP, CHI3L1 and advanced imaging measures as biomarkers of disease progression in the Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis (CanProCo)" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Raphael Schneider

Research

Latest papers

Latest funding

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial.

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis.

Plasma CHI3L1 as a marker of cognitive and structural brain changes in radiologically isolated syndrome.

Eye tracking as a digital biomarker in neurodegenerative diseases.

Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis.

Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay.

Pro-Inflammatory Molecules Implicated in Multiple Sclerosis Divert the Development of Human Oligodendrocyte Lineage Cells.

Monocyte-secreted Wnt reduces the efficiency of central nervous system remyelination.

NfL, GFAP, CHI3L1 and advanced imaging measures as biomarkers of disease progression in the Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis (CanProCo)

Investigating the CXCR4/CXCL12 axis to predict multiple sclerosis disease onset

Frequent collaborators

Jiwon Oh

Janice Robertson

Ekaterina Rogaeva

Joan Wither

Zahi Touma

Adil Harroud

Daniel Beriault

Zhaolei Zhang

Robert Laforce

Yana Yunusova

Alexandre Prat

Janusz Rak

Eric Boilard

Mario Masellis

Nathalie Arbour

Dylan Burger

Murray Urowitz

Caroline Gilbert

Ori Rotstein

Martin Olivier

Paul Fraser

Zahra Goodarzi

Shannon Kolind